Minerva Neurosciences (NERV) traded down -4.17 % during a 24 hours period ending at 05:21 PM Central Europe on Monday 26th. One Minerva Neurosciences stock can currently be bought for about USD 2.24 on popular exchanges. Current supply of Minerva Neurosciences stocks is 47.7 mn. Minerva Neurosciences has a current market capitalization of USD 109.8 mn and approximately USD 316.5 k worth of Minerva Neurosciences was traded on exchanges in the last 24 hours. Since last month end, Minerva Neurosciences has traded -33.33 % down. Simple moving average of last 200 days is at USD 4.95. The highest price of past 52 weeks was recorded at USD 8.8 on 03/16/2026. 52 weeks low was at USD 2.24 on 10/19/2026.
Here is how related stocks have performed in the past 24 hours:
Playboy (PLBY) traded down -0.91 % and now trades at USD 1.06. Playboy has a market capitalisation of USD 130.6 mn.
Nakamoto (NAKA) traded down -4.29 % and now trades at USD 7.08. Current market capitalisation for Nakamoto is USD 131.7 mn.
Greenland Energy (GLND) traded down -1.64 % and now trades at USD 3.18. Greenland Energy has a market capitalisation of USD 131.2 mn.
Magyar (MGYR) traded up 3.54 % and now trades at USD 19.8. Magyar has a market capitalisation of USD 128.5 mn. Magyar has a current price to earnings ratio of 10.37.
Spruce Biosciences (SPRB) traded down -1.85 % and now trades at USD 44.25. Spruce Biosciences has a market capitalisation of USD 129.8 mn.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, USA. The company specializes in developing new therapies for treating central nervous system (CNS) and neuropsychiatric diseases. As a biotechnology industry, it operates within the Health Care sector.
